vs
Side-by-side financial comparison of Black Stone Minerals, L.P. (BSM) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
Black Stone Minerals, L.P. is the larger business by last-quarter revenue ($95.2M vs $75.5M, roughly 1.3× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -8.7%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -9.7%).
Black Stone Minerals, L.P., or Black Stone Minerals, is a Houston, Texas-based oil and natural gas corporation.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
BSM vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $95.2M | $75.5M |
| Net Profit | $72.2M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 78.6% | 22.7% |
| Net Margin | 75.9% | — |
| Revenue YoY | -8.7% | 27.7% |
| Net Profit YoY | 55.8% | — |
| EPS (diluted) | — | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $95.2M | $75.5M | ||
| Q3 25 | $105.2M | $54.5M | ||
| Q2 25 | $106.7M | $52.4M | ||
| Q1 25 | $115.3M | $46.0M | ||
| Q4 24 | $104.3M | $59.1M | ||
| Q3 24 | $103.2M | $80.5M | ||
| Q2 24 | $115.2M | $47.1M | ||
| Q1 24 | $116.8M | $43.8M |
| Q4 25 | $72.2M | — | ||
| Q3 25 | $91.7M | $8.8M | ||
| Q2 25 | $120.0M | $5.9M | ||
| Q1 25 | $15.9M | $3.0M | ||
| Q4 24 | $46.3M | — | ||
| Q3 24 | $92.7M | $20.3M | ||
| Q2 24 | $68.3M | $-4.5M | ||
| Q1 24 | $63.9M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | 78.6% | 22.7% | ||
| Q3 25 | 89.5% | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | 14.9% | 8.7% | ||
| Q4 24 | 45.6% | 22.6% | ||
| Q3 24 | 90.2% | 27.4% | ||
| Q2 24 | 59.5% | -4.6% | ||
| Q1 24 | 54.8% | -5.3% |
| Q4 25 | 75.9% | — | ||
| Q3 25 | 87.2% | 16.2% | ||
| Q2 25 | 112.5% | 11.2% | ||
| Q1 25 | 13.8% | 6.5% | ||
| Q4 24 | 44.4% | — | ||
| Q3 24 | 89.9% | 25.2% | ||
| Q2 24 | 59.3% | -9.6% | ||
| Q1 24 | 54.7% | -11.0% |
| Q4 25 | — | $0.26 | ||
| Q3 25 | — | $0.17 | ||
| Q2 25 | — | $0.12 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | — | $0.41 | ||
| Q2 24 | — | $-0.09 | ||
| Q1 24 | — | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.5M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | — | $130.3M |
| Total Assets | $1.3B | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5M | $97.5M | ||
| Q3 25 | $2.9M | $94.4M | ||
| Q2 25 | $2.5M | $96.0M | ||
| Q1 25 | $2.4M | $93.2M | ||
| Q4 24 | $2.5M | $101.0M | ||
| Q3 24 | $21.0M | $96.7M | ||
| Q2 24 | $26.7M | $96.8M | ||
| Q1 24 | $40.5M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | — | $130.3M | ||
| Q3 25 | — | $115.3M | ||
| Q2 25 | — | $104.7M | ||
| Q1 25 | — | $97.1M | ||
| Q4 24 | — | $92.1M | ||
| Q3 24 | — | $71.1M | ||
| Q2 24 | — | $48.5M | ||
| Q1 24 | — | $51.0M |
| Q4 25 | $1.3B | $216.3M | ||
| Q3 25 | $1.3B | $202.9M | ||
| Q2 25 | $1.3B | $194.9M | ||
| Q1 25 | $1.2B | $196.2M | ||
| Q4 24 | $1.2B | $213.3M | ||
| Q3 24 | $1.2B | $220.7M | ||
| Q2 24 | $1.2B | $205.0M | ||
| Q1 24 | $1.2B | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $65.1M | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 0.90× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $65.1M | $14.4M | ||
| Q3 25 | $99.8M | $9.7M | ||
| Q2 25 | $80.5M | $14.1M | ||
| Q1 25 | $64.8M | $3.6M | ||
| Q4 24 | $91.0M | $15.6M | ||
| Q3 24 | $93.2M | $11.0M | ||
| Q2 24 | $100.4M | $1.0M | ||
| Q1 24 | $104.5M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | 0.90× | — | ||
| Q3 25 | 1.09× | 1.10× | ||
| Q2 25 | 0.67× | 2.41× | ||
| Q1 25 | 4.07× | 1.21× | ||
| Q4 24 | 1.96× | — | ||
| Q3 24 | 1.01× | 0.54× | ||
| Q2 24 | 1.47× | — | ||
| Q1 24 | 1.63× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BSM
| Oil Reserves | $46.4M | 49% |
| Natural Gas Reserves | $44.1M | 46% |
| Real Estate | $4.7M | 5% |
PBYI
Segment breakdown not available.
